RxSight, Inc.
RXST
$6.26
-$0.23-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 134.48M | 142.09M | 147.06M | 148.31M | 139.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 134.48M | 142.09M | 147.06M | 148.31M | 139.93M |
| Cost of Revenue | 31.47M | 35.55M | 39.53M | 41.72M | 40.98M |
| Gross Profit | 103.01M | 106.53M | 107.53M | 106.59M | 98.94M |
| SG&A Expenses | 112.66M | 113.25M | 111.51M | 106.83M | 101.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.67M | 187.57M | 189.59M | 185.17M | 176.78M |
| Operating Income | -48.19M | -45.48M | -42.53M | -36.86M | -36.86M |
| Income Before Tax | -38.88M | -35.66M | -32.18M | -26.49M | -27.41M |
| Income Tax Expenses | 65.00K | 72.00K | 75.00K | 59.00K | 50.00K |
| Earnings from Continuing Operations | -38.94 | -35.73 | -32.25 | -26.55 | -27.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.94M | -35.73M | -32.25M | -26.55M | -27.46M |
| EBIT | -48.19M | -45.48M | -42.53M | -36.86M | -36.86M |
| EBITDA | -44.93M | -42.55M | -39.32M | -33.63M | -33.28M |
| EPS Basic | -0.95 | -0.88 | -0.80 | -0.67 | -0.71 |
| Normalized Basic EPS | -0.59 | -0.55 | -0.50 | -0.42 | -0.44 |
| EPS Diluted | -0.95 | -0.88 | -0.80 | -0.67 | -0.71 |
| Normalized Diluted EPS | -0.59 | -0.55 | -0.50 | -0.42 | -0.44 |
| Average Basic Shares Outstanding | 163.39M | 162.58M | 161.40M | 159.11M | 155.44M |
| Average Diluted Shares Outstanding | 163.39M | 162.58M | 161.40M | 159.11M | 155.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |